ClinicalTrials.gg

Drug

Artemether clinical trials

studies test it
17
open now
1
in phase 3
2
first study started
2004

Keep track of what changes. Save the Artemether studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

16 studies that test it; most in 2012 (3)

Studies that test Artemether, by start year
YearStudies
20041
20052
20061
20081
20092
20111
20123
20142
20161
20221
20241

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
2
Phase 3
2
Phase 4
9

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 4 · Other 13

University of California, San Francisco (2) · University of Cape Town (2) · Centers for Disease Control and Prevention (1) · Epicentre (1) · Thierry Buclin (1) · GlaxoSmithKline (1) · Universiteit Antwerpen (1) · Muhimbili University of Health and Allied Sciences (1)

Often tested with

Tested in the same studies.

Lumefantrine (14) · Artesunate (3) · Amodiaquine (3) · Tafenoquine (2) · Efavirenz (2) · Quinine (1) · Sulfadoxine (1) · Pyrimethamine (1)

Studies

Open first, then newest update. How each study uses Artemether is read from its arms, and is right about nine times in ten.

Testing it · 17

Given in every arm · 6 — Artemether is usual care beside what is tested
As the comparator · 3 — what is tested is compared with Artemether

Codes

What other systems call Artemether · ClinicalTrials.gg INT006745

  • MeSH (NLM) D000077549ArtemetherConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) C7D6T3H22JARTEMETHERConfirmed FDA, NLM, Wikidata
  • RxNorm 18343Confirmed FDA, Wikidata
  • Wikidata Q416199artemetherConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C73001ArtemetherOne source FDA
  • DrugBank DB06697One source Wikidata

Also registered as .alpha.-artemether (UNII 111W6L37CC).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.